These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20283827)

  • 1. Partial maturation of leukemic myeloblasts following plasma transfusions.
    SCHWIND JL
    Am J Med Sci; 1947 Feb; 213(2):170-5. PubMed ID: 20283827
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial maturation of leukemic myeloblasts following fresh plasma transfusions.
    SCHWIND JL
    Anat Rec; 1946 Mar; 94():526. PubMed ID: 21066293
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.
    Hanekamp D; Bachas C; van de Loosdrecht A; Ossenkoppele G; Cloos J
    Pathology; 2020 Feb; 52(2):289-291. PubMed ID: 31883670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial of statistical interpretation of the maturation and division of erythroblasts and myeloblasts; its formulation in the system of logarithms to the base 2].
    DEVIGNAT R
    Rev Hematol; 1956; 11(1):8-16. PubMed ID: 13336829
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes: author reply.
    Camburn AE; Petrasich M; Ruskova A; Chan G
    Pathology; 2020 Feb; 52(2):291. PubMed ID: 31928759
    [No Abstract]   [Full Text] [Related]  

  • 6. [OXIDASE-NEGATIVE MYELOBLASTS IN NORMAL BONE MARROW].
    OHKITA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Feb; 26():122-4. PubMed ID: 14043456
    [No Abstract]   [Full Text] [Related]  

  • 7. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
    Woźniak J; Kopeć-Szlezak J
    Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIM3 expression by leukemic and non-leukemic myeloblasts.
    Roth CG; Garner K; Eyck ST; Boyiadzis M; Kane LP; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):167-72. PubMed ID: 23554257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ON OXIDASE-NEGATIVE MYELOBLASTS IN LEUKEMIA WITH SPECIAL REFERENCE TO THEIR ELECTRON MICROSCOPE PICTURE].
    ITO T
    Nihon Ketsueki Gakkai Zasshi; 1963 Feb; 26():139-42. PubMed ID: 14043461
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative analysis of the mitotic activity of normal and leukemic myelocytes in rats with and without urethane treatment.
    ROSIN A; GOLDHABER G
    Acta Haematol; 1958 Nov; 20(5):318-28. PubMed ID: 13605581
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of factors determining the usefulness and complications of leukocyte transfusions.
    Schwarzenberg L; Mathé G; Amiel JL; Cattan A; Schneider M; Schlumberger JR
    Am J Med; 1967 Aug; 43(2):206-13. PubMed ID: 5231419
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE ESSENTIAL NATURE OF NADI-NEGATIVE MYELOBLASTS].
    AMANO S
    Nihon Ketsueki Gakkai Zasshi; 1963 Feb; 26():121-2. PubMed ID: 14043455
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell multiplication, virus liberation, and ultrastrcuture of avain myeloblasts in tissue culture.
    PARSONS DF; BEAUDREAU GS; BECKER C; BONAR RA; BEARD JW
    Acta Unio Int Contra Cancrum; 1959; 15():826-31. PubMed ID: 14430622
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia.
    Stryckmans P; Debusscher L; Socquet M
    Cancer Res; 1976 Sep; 36(9 pt.1):3034-8. PubMed ID: 1067897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow.
    Baley JE; Bruce M; Stork EK; Klinger JD; Medvik K; Shurin S
    J Lab Clin Med; 1990 Mar; 115(3):283-91. PubMed ID: 2313160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial phagocytic power of myelocytes and histiocytes of human bone marrow in vitro].
    PETRONELLI A
    Boll Soc Ital Biol Sper; 1952 Jul; 28(7):1408-10. PubMed ID: 13018791
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of infections in granulocytopenic patients with granulocyte transfusions.
    Mód A; Harsányi V; Jakschitz M; Hollán SR
    Haematologia (Budap); 1977; 11(1-2):31-40. PubMed ID: 352851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusion therapy.
    Higby DJ; Henderson ES
    Annu Rev Med; 1975; 26():289-316. PubMed ID: 1096766
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia.
    Oka S; Muroi K; Matsuyama T; Sato K; Ueda M; Toshima M; Suzuki T; Ozaki K; Mori M; Takubo T; Nagai T; Hanafusa T; Ozawa K
    Hematology; 2009 Jun; 14(3):133-8. PubMed ID: 19490757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.